SCANCELL HOLDINGS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.6 GBX | +0.52% |
|
-4.95% | -8.57% |
| Mar. 26 | Scancell doses first patient in melanoma-focused trials | AN |
| Mar. 22 | Seneca Growth Capital announces tepid 2023 results | AN |
Chart calendar Scancell Holdings plc
c4bafdd4fce867757688.EwS22H7W50soW1Gs_cP5j-EbjDWmizOjLEmGlaA0s2M.XD316hm1030FIQnovvDA4bNI_XHyw2XqSzzW59RQ8DdGQO_oS4LREkkQAA~d70dce62839056d4d6da58344bd70790
Upcoming events on Scancell Holdings plc
Past events on Scancell Holdings plc
| 2024-04-07 06:50 pm | American Association for Cancer Research Meeting - Abstract Number : CT024 |
| 2024-03-17 | BioEurope Spring Conference |
| 2024-03-15 11:10 am | Oxford Global Biologics Conference |
| 2024-03-13 01:00 pm | ADC London Conference |
| 2024-03-07 09:45 am | Next Gen Immuno Oncology Conference |
| 2024-01-30 09:00 am | Q2 2024 Earnings Call |
| 2024-01-30 02:00 am | Q2 2024 Earnings Release |
| 2023-11-29 09:00 am | Annual General Meeting |
| 2023-11-03 09:00 am | Society for Immunotherapy of Cancer Meeting - Abstract No - 1533 |
| 2023-10-31 03:00 am | Q4 2023 Earnings Release |
| 2023-10-24 11:30 am | Q4 2023 Earnings Call - Second Call |
| 2023-10-24 05:00 am | Q4 2023 Earnings Call - First Call |
| 2023-10-19 05:00 am | Europe World Vaccine Congress |
| 2023-09-22 06:45 am | CRI ENCI AACR International Cancer Immunotherapy Conference - Poster No - 3 |
| 2023-09-21 06:30 am | CRI ENCI AACR International Cancer Immunotherapy Conference - Poster No - 2 |
| 2023-09-21 06:30 am | CRI ENCI AACR International Cancer Immunotherapy Conference - Poster No - 1 |
| 2023-09-19 08:00 am | SCIB1 Phase 2 SCOPE Trial Results Call |
| 2023-06-03 09:00 am | American Society of Clinical Oncology Conference - Abstract 2566 |
| 2023-04-18 01:30 pm | American Association for Cancer Research Meeting - Abstract - CT256/19 |
| 2022-11-21 09:00 am | Annual General Meeting |
Annual results
| Fiscal Period | April | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 5,27 3,52 49.59% | 0,00 |
|
EBITDA Million GBP | Released Forecast Spread | -6,71 -7,91 15.23% | -6,74 -6,99 3.56% | -8,59 -9,07 5.35% | -12,6 -14,5 13.41% | -11,0 -16,0 30.94% | -17,2 |
|
EBIT Million GBP | Released Forecast Spread | -6,73 -7,95 15.33% | -6,78 -7,02 3.35% | -8,83 -9,13 3.24% | -13,3 -14,8 10.28% | -11,9 -16,3 26.97% | -18,0 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -6,71 -7,96 15.68% | -6,77 -7,01 3.47% | -16,8 -9,60 -75.05% | -3,77 -10,9 65.36% | -14,3 -20,4 29.93% | -15,8 |
|
Net income Million GBP | Released Forecast Spread | -5,63 -6,67 15.69% | -5,51 -5,91 6.83% | -15,5 -8,38 -84.74% | -2,07 -4,98 58.51% | -11,9 -14,4 16.92% | -14,8 |
|
EPS GBP | Released Forecast Spread | -0,01 -0,02 14.71% | -0,01 -0,01 3.2% | -0,02 -0,02 -26.67% | 0,00 -0,01 78.99% | -0,02 -0,02 27.78% | -0,02 |
| Announcement Date | 20/08/19 | 16/10/20 | 29/10/21 | 28/10/22 | 31/10/23 | - |
More events
Past sector events for Scancell Holdings plc
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SCLP Stock
- Calendar Scancell Holdings plc
